600420 国药现代
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.9698.4686.0986.6446.796
总资产报酬率 ROA (%)4.0795.5143.5503.2443.045
投入资产回报率 ROIC (%)5.2937.3214.7704.5274.369

边际利润分析
销售毛利率 (%)33.29339.24438.32638.07943.721
营业利润率 (%)15.94916.0188.9617.4556.436
息税前利润/营业总收入 (%)15.55314.4868.4607.2387.302
净利润/营业总收入 (%)13.48512.1797.9926.6945.888

收益指标分析
经营活动净收益/利润总额(%)95.054103.30197.60193.010113.710
价值变动净收益/利润总额(%)6.1223.8322.5040.238-2.618
营业外收支净额/利润总额(%)1.056-4.7141.3621.8272.249

偿债能力分析
流动比率 (X)3.2132.6902.8202.7851.591
速动比率 (X)2.6232.1812.2162.2031.142
资产负债率 (%)18.79023.22025.90938.09245.622
带息债务/全部投入资本 (%)7.64411.28512.50627.27732.130
股东权益/带息债务 (%)1,184.619769.220688.287258.420203.870
股东权益/负债合计 (%)375.482284.958247.072137.81798.766
利息保障倍数 (X)-27.500-17.866-13.525-20.33410.180

营运能力分析
应收账款周转天数 (天)41.32038.78948.22258.16251.204
存货周转天数 (天)122.584121.599114.136123.644145.722